Corgenix gets grant to develop Ebola and Marburg virus tests
This article was originally published in Clinica
Executive Summary
The US National Institutes of Health has awarded IVD firm Corgenix Medical a $600,000 grant to help develop tests for two tropical viruses: Ebola and Marburg. The grant will support a two-year study, which Corgenix expects to aid the development of “specific, cost-effective and easy-to-use tests” for both viruses. These could eventually lead to vaccines and treatments, the Denver, Colorado company hopes. Several other institutions are collaborating on the project, including Tulane University in New Orleans, Louisiana, and The Scripps Research Institute in La Jolla, California. Both the Ebola and Marburg viruses are found in Africa and cause haemorrhagic fevers, characterised by bleeding and coagulation abnormalities. Ebola is fatal in up to 90% of cases.